Yakult Honsha Co Ltd
TSE:2267
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 765
3 441
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Yakult Honsha Co Ltd
Yakult Honsha Co Ltd
Income to Minority Interest
Yakult Honsha Co Ltd
Income to Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yakult Honsha Co Ltd
TSE:2267
|
Income to Minority Interest
-¥9.1B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Ajinomoto Co Inc
TSE:2802
|
Income to Minority Interest
-¥15.7B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-7%
|
|
|
Meiji Holdings Co Ltd
TSE:2269
|
Income to Minority Interest
-¥2.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Kikkoman Corp
TSE:2801
|
Income to Minority Interest
-¥467m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-31%
|
|
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
Income to Minority Interest
-¥4.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Toyo Suisan Kaisha Ltd
TSE:2875
|
Income to Minority Interest
¥430m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yakult Honsha Co Ltd
Glance View
Yakult Honsha Co., Ltd., a company rooted in Japanese tradition and scientific innovation, has become a global powerhouse in the probiotics industry. The journey began in 1935 when microbiologist Minoru Shirota pioneered the development of a fermented milk drink containing a unique strain of bacteria, Lactobacillus casei Shirota. This visionary endeavor aimed to improve gut health utilizing the principles of preventive medicine, a novel concept at the time. Yakult's flagship product, a small, iconic bottle of sweet-tasting probiotic milk, swiftly captured the attention and trust of Japanese consumers, setting the company on a trajectory of continuous growth and worldwide expansion. The company leveraged its strong research foundation to consistently innovate its product offerings, ensuring Yakult remained at the forefront of the health and wellness trend. In the modern marketplace, Yakult's operations exemplify a successful case of strategic internationalization. By maintaining a robust distribution network across more than 40 countries, the company effectively taps into varying health consciousness trends across diverse cultures. Revenue is primarily derived from the sales of its probiotic beverages, which are produced through a time-honored fermentation process. Yakult has strengthened its market position through direct sales strategies, including the hallmark “Yakult Ladies,” who personally deliver products to customers, enhancing consumer engagement and fostering brand loyalty. Beyond beverages, Yakult has diversified its portfolio to include cosmetics and pharmaceuticals, though the probiotic drinks remain its core profit engine. This diversification not only draws on the company's microbiological expertise but also mitigates risk by reducing dependency on a single product line.
See Also
What is Yakult Honsha Co Ltd's Income to Minority Interest?
Income to Minority Interest
-9.1B
JPY
Based on the financial report for Sep 30, 2024, Yakult Honsha Co Ltd's Income to Minority Interest amounts to -9.1B JPY.
What is Yakult Honsha Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
-7%
Over the last year, the Income to Minority Interest growth was -63%. The average annual Income to Minority Interest growth rates for Yakult Honsha Co Ltd have been -31% over the past three years , -12% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
